Ownership Submission
FORM 5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
Form 3 Holdings Reported
Form 4 Transactions Reported
UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

ANNUAL STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934, Section 17(a) of the Public Utility Holding Company Act of 1935 or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0362
Expires: January 31, 2005
Estimated average burden hours per response... 1.0

1. Name and Address of Reporting Person *
JOHNSON & JOHNSON
 2. Issuer Name and Ticker or Trading Symbol
UNIVERSAL BIOSENSORS INC [UBI] 		5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
_____ Director __X__ 10% Owner
_____ Officer (give title below) _____ Other (specify below)
(Last)
(First)
(Middle)

ONE JOHNSON & JOHNSON PLAZA		 3. Statement for Issuer's Fiscal Year Ended (Month/Day/Year)
12/31/2011
(Street)


NEW BRUNSWICK, NJ 08933		 4. If Amendment, Date Original Filed(Month/Day/Year)
 6. Individual or Joint/Group Reporting
(check applicable line)

___ Form Filed by One Reporting Person
_X_ Form Filed by More than One Reporting Person
(City)
(State)
(Zip)
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1.Title of Security
(Instr. 3)		 2. Transaction Date (Month/Day/Year) 2A. Deemed Execution Date, if any (Month/Day/Year) 3. Transaction Code
(Instr. 8)		 4. Securities Acquired (A) or Disposed of (D)
(Instr. 3, 4 and 5)		 5. Amount of Securities Beneficially Owned at end of Issuer's Fiscal Year
(Instr. 3 and 4)		 6. Ownership Form: Direct (D) or Indirect (I)
(Instr. 4)		 7. Nature of Indirect Beneficial Ownership
(Instr. 4)
Amount (A) or (D) Price
Common Stock 01/12/2011   S4 50,000 D $ 1.49 18,157,030 I By Johnson & Johnson Development Corporation (1)
Common Stock 01/13/2011   S4 50,000 D $ 1.5 18,107,038 I By Johnson & Johnson Development Corporation (1)
Common Stock 01/14/2011   S4 50,000 D $ 1.48 18,057,030 I By Johnson & Johnson Development Corporation (1)
Common Stock 01/18/2011   S4 50,000 D $ 1.51 18,007,030 I By Johnson & Johnson Development Corporation (1)
Common Stock 01/19/2011   S4 50,000 D $ 1.52 17,957,030 I By Johnson & Johnson Development Corporation (1)
Common Stock 01/20/2011   S4 50,000 D $ 1.51 17,907,030 I By Johnson & Johnson Development Corporation (1)
Common Stock 01/21/2011   S4 50,000 D $ 1.51 17,857,030 I By Johnson & Johnson Development Corporation (1)
Common Stock 01/24/2011   S4 50,000 D $ 1.51 17,807,030 I By Johnson & Johnson Development Corporation (1)
Common Stock 01/25/2011   S4 73 D $ 1.52 17,806,957 I By Johnson & Johnson Development Corporation (1)
Common Stock 01/27/2011   S4 17,869 D $ 1.51 17,789,088 I By Johnson & Johnson Development Corporation (1)
Common Stock 01/28/2011   S4 50,000 D $ 1.52 17,739,088 I By Johnson & Johnson Development Corporation (1)
Common Stock 01/31/2011   S4 50,000 D $ 1.5 17,689,088 I By Johnson & Johnson Development Corporation (1)
Common Stock 02/01/2011   S4 50,000 D $ 1.52 17,639,088 I By Johnson & Johnson Development Corporation (1)
Common Stock 02/02/2011   S4 50,000 D $ 1.53 17,589,088 I By Johnson & Johnson Development Corporation (1)
Common Stock 02/07/2011   S4 50,000 D $ 1.38 17,584,088 I By Johnson & Johnson Development Corporation (1)
Common Stock 02/08/2011   S4 10,000 D $ 1.37 17,574,088 I By Johnson & Johnson Development Corporation (1)
Common Stock 02/09/2011   S4 22 D $ 1.36 17,574,066 I By Johnson & Johnson Development Corporation (1)
Common Stock 02/11/2011   S4 22,463 D $ 1.38 17,551,603 I By Johnson & Johnson Development Corporation (1)
Common Stock 02/15/2011   S4 5,000 D $ 1.36 17,546,603 I By Johnson & Johnson Development Corporation (1)
Common Stock 02/16/2011   S4 5,000 D $ 1.36 17,541,603 I By Johnson & Johnson Development Corporation (1)
Common Stock 02/17/2011   S4 5,000 D $ 1.35 17,536,603 I By Johnson & Johnson Development Corporation (1)
Common Stock 02/18/2011   S4 5,000 D $ 1.36 17,531,603 I By Johnson & Johnson Development Corporation (1)
Common Stock 02/23/2011   S4 37,279 D $ 1.52 17,494,324 I By Johnson & Johnson Development Corporation (1)
Common Stock 02/25/2011   S4 2,590 D $ 1.42 17,491,734 I By Johnson & Johnson Development Corporation (1)
Common Stock 02/28/2011   S4 1,083 D $ 1.42 17,490,651 I By Johnson & Johnson Development Corporation (1)
Common Stock 03/01/2011   S4 34 D $ 1.42 17,490,617 I By Johnson & Johnson Development Corporation (1)
Common Stock 03/03/2011   S4 10,000 D $ 1.42 17,480,617 I By Johnson & Johnson Development Corporation (1)
Common Stock 03/04/2011   S4 24,000 D $ 1.42 17,456,617 I By Johnson & Johnson Development Corporation (1)
Common Stock 03/07/2011   S4 25,000 D $ 1.42 17,431,617 I By Johnson & Johnson Development Corporation (1)

Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly. Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB control number. SEC 2270 (9-02)

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security
(Instr. 3)		 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year) 3A. Deemed Execution Date, if any (Month/Day/Year) 4. Transaction Code
(Instr. 8)		 5. Number of Derivative Securities Acquired (A) or Disposed of (D)
(Instr. 3, 4, and 5)		 6. Date Exercisable and Expiration Date
(Month/Day/Year)		 7. Title and Amount of Underlying Securities
(Instr. 3 and 4)		 8. Price of Derivative Security
(Instr. 5)		 9. Number of Derivative Securities Beneficially Owned at End of Issuer's Fiscal Year
(Instr. 4)		 10. Ownership Form of Derivative Security: Direct (D) or Indirect (I)
(Instr. 4)		 11. Nature of Indirect Beneficial Ownership
(Instr. 4)
(A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares

Reporting Owners

Reporting Owner Name / Address Relationships
Director 10% Owner Officer Other
JOHNSON & JOHNSON
ONE JOHNSON & JOHNSON PLAZA
NEW BRUNSWICK, NJ 08933		     X    
JOHNSON & JOHNSON DEVELOPMENT CORP ET AL
ONE JOHNSON & JOHNSON PLAZA
NEW BRUNSWICK, NJ 08933		     X    

Signatures

/s/ Douglas Chia, Secretary of Johnson & Johnson 01/20/2012
**Signature of Reporting Person Date
/s/ Jayne Zall, Secretary of Johnson & Johnson Development Corporation 01/20/2012
**Signature of Reporting Person Date

Explanation of Responses:

* If the form is filed by more than one reporting person, see Instruction 4(b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations. See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
(1) The securities reported as being indirectly beneficially owned by the Reporting Person are directly beneficially owned by Johnson & Johnson Development Corporation, a wholly-owned subsidiary of the Reporting Person.
 
Remarks:
First of Two Forms

Note: File three copies of this Form, one of which must be manually signed. If space provided is insufficient, see Instruction 6 for procedure.

Potential persons who are to respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB number.